Lung cancer metastasis-related protein 1 promotes the transferring from advanced metastatic prostate cancer to castration-resistant prostate cancer by activating the glucocorticoid receptor α signal pathway

References

• Eeles R, Goh C, Castro E, et al. The genetic epidemiology of prostate cancer and its clinical implications. Nature Rev Urol. 2014;11:18–31.
   PubMed Web of Science ®Google Scholar
• Gronberg H. Prostate cancer epidemiology. Lancet. 2003;361:859–864.
   PubMed Web of Science ®Google Scholar
• Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–2150.
   PubMed Web of Science ®Google Scholar
• Ye D, Zhu Y. Epidemiology of prostate cancer in China: an overview and clinical implication. Zhonghua Wai Ke Za Zhi. 2015;53:249–252.
   PubMedGoogle Scholar
• Siddiqui K, Abbas F, Biyabani SR, et al. Role of estrogens in the secondary hormonal manipulation of hormone refractory prostate cancer. JPMA. 2004;54:445–447.
   Google Scholar
• Small EJ, Harris KA. Secondary hormonal manipulation of prostate cancer. Semin Urol Oncol. 2002;20:24–30.
   PubMedGoogle Scholar
• Stock RG, Stone NN. Current topics in the treatment of prostate cancer with low-dose-rate brachytherapy. Urol Clin North Am. 2010;37:83–96, Table of Contents.
   PubMed Web of Science ®Google Scholar
• Kuronya Z, Biro K, Gyergyay F, et al. [Androgen receptor-mediated processes in castrate-resistant metastatic prostate cancer]. Orv Hetil. 2017;158:42–49.
   PubMed Web of Science ®Google Scholar
• Shankar S, Ganapathy S, Srivastava RK. Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis. Clin Cancer Res. 2008;14:6855–6866.
   PubMed Web of Science ®Google Scholar
• Misawa A, Takayama KI, Inoue S. Long non-coding RNAs and prostate cancer. Cancer Sci. 2017;108:2107–2114.
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428–435.
   PubMed Web of Science ®Google Scholar
• Deshmukh SK, Srivastava SK, Poosarla T, et al. Inflammation, immunosuppressive microenvironment and breast cancer: opportunities for cancer prevention and therapy. Ann Transl Med. 2019;7:593.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–867.
   PubMed Web of Science ®Google Scholar
• Kwon OJ, Zhang L, Ittmann MM, et al. Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin. Proc Natl Acad Sci USA. 2014;111:E592–600.
   PubMed Web of Science ®Google Scholar
• Silverman MN, Sternberg EM. Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci. 2012;1261:55–63.
   PubMed Web of Science ®Google Scholar
• Arora VK, Schenkein E, Murali R, et al. Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade. Cell. 2013;155:1309–1322.
   PubMed Web of Science ®Google Scholar
• Vieth M, Kushima R, Mukaisho K, et al. Immunohistochemical analysis of pyloric gland adenomas using a series of Mucin 2, Mucin 5AC, Mucin 6, CD10, Ki67 and p53. Virchows Arch. 2010;457:529–536.
   PubMed Web of Science ®Google Scholar
• Lin X, Bai D, Wei Z, et al. Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway. PloS One. 2019;14:e0216711.
   PubMed Web of Science ®Google Scholar
• Cappiello F, Casciaro B, Mangoni ML. A novel in vitro wound healing assay to evaluate cell migration. J Visual Exp. 2018. DOI:10.3791/56825
   PubMed Web of Science ®Google Scholar
• Yang H, Lv H, Li H, et al. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-kappaB pathways. Cell Commun Signal. 2019;17:62.
   PubMed Web of Science ®Google Scholar
• Alcaraz-Perez F, Mulero V, Cayuela ML. Application of the dual-luciferase reporter assay to the analysis of promoter activity in Zebrafish embryos. BMC Biotechnol. 2008;8:81.
   PubMed Web of Science ®Google Scholar
• Jurisic V, Srdic-Rajic T, Konjevic G, et al. TNF-alpha induced apoptosis is accompanied with rapid CD30 and slower CD45 shedding from K-562 cells. J Membrane Biol. 2011;239:115–122.
   PubMed Web of Science ®Google Scholar
• Ma Y, Ren Y, Dai ZJ, et al. IL-6, IL-8 and TNF-alpha levels correlate with disease stage in breast cancer patients. Adv Clin Exp Med. 2017;26:421–426.
   PubMed Web of Science ®Google Scholar
• Jurisic V. Multiomic analysis of cytokines in immuno-oncology. Expert Rev Proteom. 2020;17:663–674.
   PubMed Web of Science ®Google Scholar
• Yan C, Brunson DC, Tang Q, et al. Visualizing engrafted human cancer and therapy responses in immunodeficient zebrafish. Cell. 2019;177:1903–14 e14.
   PubMed Web of Science ®Google Scholar
• Quan Y, Cui Y, Wahafu W, et al. MLL5alpha activates AR/NDRG1 signaling to suppress prostate cancer progression. Am J Cancer Res. 2020;10:1608–1629.
   PubMed Web of Science ®Google Scholar
• Adisetiyo H, Liang M, Liao CP, et al. Dependence of castration-resistant prostate cancer (CRPC) stem cells on CRPC-associated fibroblasts. J Cell Physiol. 2014;229:1170–1176.
   PubMed Web of Science ®Google Scholar
• Xu SG, Yu JJ, Shi Q, et al. Conditionally replicative adenovirus carrying shRNA targeting EZH2 inhibits prostate cancer growth and invasion. Oncol Rep. 2019;42:273–282.
   PubMed Web of Science ®Google Scholar
• You B, Zhang KC. MicroRNA-144-3p inhibits cell proliferation and promotes apoptosis in castration-resistant prostate cancer by targeting CEP55. Eur Rev Med Pharmacol Sci. 2018;22:7660–7670.
   PubMed Web of Science ®Google Scholar
• You Z, Liu C, Wang C, et al. LncRNA CCAT1 promotes prostate cancer cell proliferation by interacting with DDX5 and MIR-28-5P. Mol Cancer Therap. 2019;18:2469–2479.
   PubMed Web of Science ®Google Scholar
• Guan H, You Z, Wang C, et al. MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathway. Cancer Med. 2019;8:1474–1485.
   PubMed Web of Science ®Google Scholar
• Sato S, Tomomori-Sato C, Banks CA, et al. A mammalian homolog of Drosophila melanogaster transcriptional coactivator intersex is a subunit of the mammalian mediator complex. J Biol Chem. 2003;278:49671–49674.
   PubMed Web of Science ®Google Scholar
• Yu W, Zhang Z, Min D, et al. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis. Eur J Cancer. 2014;50:1125–1136.
   PubMed Web of Science ®Google Scholar
• Kassi E, Moutsatsou P. Glucocorticoid receptor signaling and prostate cancer. Cancer Lett. 2011;302:1–10.
   PubMed Web of Science ®Google Scholar